Release Date: 01/08/22 07:53 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 1.57MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%